Company
Decisions in the clinic
Overview
Brainscore Coma
Drug development
Newsroom
Join us
Contact
News & events
11 January 2023
BrainTale has presented the interest if its digital biomarkers platform in differential diagnosis during the 15th edition of Clinical Trials on Alzheimer’s Disease conference
5 September 2022
American Academy of Neurology (AAN 2022) – Braintale showcases together with Minoryx data from its biomarker platform for disease and treatment monitoring of X-linked Adrenoleukodystrophy and strengthens collaboration
7 April 2022
French Grand Est region: Braintale presents promising results on Amyotrophic Lateral Sclerosis and announces a partnership with the University Hospitals of Strasbourg
